Navigation Links
University Hospitals Selects GenomOncology's GO Clinical Workbench to Launch their first NGS-based Cancer Diagnostic Test
Date:10/27/2014

CLEVELAND, Oct. 27, 2014 /PRNewswire/ -- GenomOncology today announced that University Hospitals (UH) Case Medical Center and UH Seidman Cancer Center (Cleveland, Ohio) have selected the company's GO Clinical WorkbenchTM to launch a clinical cancer product. UH will leverage the GO Clinical Workbench for workflow management from raw sequencing data through delivery of an actionable clinical report for oncologists.

UH, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 26 outpatient centers and primary care physician offices in 15 counties. Its main campus includes UH Case Medical Center, UH Rainbow Babies & Children's Hospital, UH MacDonald Women's Hospital, and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University.

"Cancer research not only advances cancer treatment, it also provides a source of hope and help to patients for whom other treatments have failed," said Joseph Willis, MD, Division Chief, Clinical Pathology at UH Case Medical Center. "Coupling our research efforts with the powerful analytics provided by the GO Clinical Workbench will allow us to quickly translate scientific findings into the highest quality patient care."

GenomOncology's GO Clinical Workbench streamlines the use of Next Generation Sequencing (NGS) data and allows molecular pathology laboratories to produce an actionable clinical report using the molecular profile of an individual patient's tumor. The platform is configured to each clinical laboratory's specific needs with systems integration (LIMS, EMR, etc.), setting of quality control and annotation parameters, and design of the resultant clinical report.

"GenomOncology is honored to have our GO Clinical Workbench selected by University Hospitals, one of the nation's leading health care systems," said Manuel Glynias, President and CEO of GenomOncology. "We are confident that our robust technology platform and onsite support will allow University Hospitals to continue to provide the most advanced care to their patients."

About University Hospitals

University Hospitals, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 28 outpatient health centers and primary care physician offices in 15 counties. At the core of our $3.5 billion health system is University Hospitals Case Medical Center, ranked among America's 50 best hospitals by U.S. News & World Report in all 12 methodology-ranked specialties. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to www.uhhospitals.org

About GenomOncology

GenomOncology is enabling precision medicine by translating next generation sequencing data into actionable information for clinicians and researchers. In collaboration with molecular pathologists and physicians, GenomOncology has developed the GO Clinical WorkbenchTM, a decision support tool with a step-by-step workflow that takes raw data from the sequencer and translates the specific molecular profile of each patient's tumor genome into an actionable clinical report.  GenomOncology's research platform, GenomAnalyticsTM, allows scientists to analyze one or hundreds of genomes simultaneously to look for causal variants, reducing the time required to understand the genomic alterations that lead to new discoveries about the biology of cancer. More information can be found on the company's website at www.genomoncology.com.

For more information regarding this announcement, please contact:

Jane Krug, PR Contact
Phone: 504-390-5935
Email:  jane@genomoncology.com 

Logo - http://photos.prnewswire.com/prnh/20140204/CL58248LOGO


'/>"/>
SOURCE GenomOncology
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
4. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
8. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
9. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
10. Oregon State University Launches New Online Learning System For Pharmacy Managers
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2019)... ... December 05, 2019 , ... ... Services (AWS) Public Sector Partner Program; a designation that will accelerate digital ... and collaborates with partners that offer solutions and proven experience delivering on ...
(Date:12/5/2019)... ... , ... nView, a leading behavioral health solutions company, is ... Product Officer. As the company expands its portfolio of software solutions, Rosenbaum will ... into nView’s product and company growth strategy. Rosenbaum will report directly to nView ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... improved financial, operational and clinical health for our partners, today announced Steve ... American College of Healthcare Executives (ACHE). , ACHE is an international professional ...
Breaking Medicine Technology:
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... era of assembling and manufacturing implantable medical devices, which is a new and ... the name suggests, implantable medical devices are surgically inserted into various parts of ...
(Date:12/6/2019)... ... ... Lasair Aesthetic Health Sponsors Toys for Tots to Give Free Toys to Children in Need ... Toys During the Holidays , Lasair Aesthetic Health is spreading holiday cheer again this year ... a toy or toys worth more than 25-dollars, will get FIVE units of Botox (a ...
(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 graduate of ... on the health benefits of coconut oil in the 7 November 2019 edition of ... the Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. Santos, examines ...
(Date:12/5/2019)... ... 05, 2019 , ... Intelligent.com, a trusted resource for online ... Programs for 2020. The comprehensive research guide is based on an assessment of ... on curriculum quality, graduation rate, reputation, and post-graduate employment. , The 2020 ...
(Date:12/4/2019)... THE SEA, Calif. (PRWEB) , ... December 04, ... ... fruit, trademarked as Tex-OE, Opuntia Mesocarp Extract®, provides protection from disruptions to cells ... effective at countering the menace of Jet Lag, is available in a dietary ...
Breaking Medicine News(10 mins):